Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$0.4201 -7%
Market Cap
$26.1M
Price Target
Refer to Report
Volume
179.6K
52wk Range
$0.257 - $1.33
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.